عرض بسيط للتسجيلة

المؤلفMoustafa, Diala Alhaj
المؤلفImran, Zainab
المؤلفIsmail, Roua
المؤلفRayan, Menatallah
المؤلفGadeau, Alain Pierre
المؤلفEldassouki, Hussein
المؤلفAbdulrahman, Nabeel
المؤلفMraiche, Fatima
تاريخ الإتاحة2023-03-27T10:19:21Z
تاريخ النشر2022-03-01
اسم المنشورMolecular Biology Reports
المعرّفhttp://dx.doi.org/10.1007/s11033-022-07183-w
الاقتباسMoustafa, D.A., Imran, Z., Ismail, R. et al. Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin–angiotensin–aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study. Mol Biol Rep 49, 2321–2324 (2022). https://doi.org/10.1007/s11033-022-07183-w
الرقم المعياري الدولي للكتاب03014851
معرّف المصادر الموحدhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85124154184&origin=inward
معرّف المصادر الموحدhttp://hdl.handle.net/10576/41352
الملخصNumerous studies demonstrate parallels between CVD, type 2 diabetes mellitus (T2DM) and COVID-19 pathology, which accentuate pre-existing complications in patients infected with COVID-19 and potentially exacerbate the infection course. Antidiabetic drugs such as sodium-glucose transporter-2 (SGLT-2) inhibitors have garnered substantial attention recently due to their efficacy in reducing the severity of cardiorenal disease. The effect of SGLT-2 inhibitors in patients with COVID-19 remains unclear particularly since SGLT-2 inhibitors contribute to altering the RAAS cascade activity, which includes ACE-2, the major cell entry receptor for SARS-CoV2. A study, DARE-19, was carried out to unveil the effects of SGLT-2 inhibitor treatment on comorbid disease complications and concomitant COVID-19 outcomes and demonstrated no statistical significance. However, the need for further studies is essential to provide conclusive clinical findings.
راعي المشروعThis project was supported by Qatar University Student Grant No: QUST-2-CPH-2020-16. “The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.”
اللغةen
الناشرSpringer
الموضوعACE-2
COVID-19
Dapagliflozin
DARE-19
Renin angiotensin aldosterone system
SGLT-2
العنوانEvaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin–angiotensin–aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study
النوعArticle Review
الصفحات2321-2324
رقم العدد3
رقم المجلد49
ESSN1573-4978
dc.accessType Abstract Only


الملفات في هذه التسجيلة

الملفاتالحجمالصيغةالعرض

لا توجد ملفات لها صلة بهذه التسجيلة.

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة